Addition of COVID Laboratory Results Data to the Sentinel Common Data Model (SCDM) and Establishment of a “Freshest Feasible” Rapid COVID-19 Data Resource

Basic Details
Date Posted
Monday, September 14, 2020
Status
In progress
Health Outcome(s)
COVID-19
Description

This project supports FDA’s COVID-19 response through: 

  1. Adding COVID-19 laboratory results data to the Sentinel Common Data Model (SCDM) for routine querying in the Active Risk Identification and Analysis (ARIA) system
  2. Developing access to the “freshest feasible” rapid COVID-19 data from Sentinel data partners in the distributed data network 
Deliverable(s) (1)
Sentinel Common Data Model version 7.1.0
Information
Time Period
January 1, 2018 - Current
Population / Cohort
All individuals
Data Source(s)
Select Sentinel Data Partners
Related Links
Related Link(s)
FDA Sentinel System’s Coronavirus (COVID-19) Activities
Sentinel Common Data Model
Workgroup Leader(s)

Julie Richard; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA

Workgroup Member(s)

Judith C. Maro, PhD, MS; Laura Shockro; Christine Halbig, MPH; Daniel Scarnecchia, MPIA; Neesha Nathwani; Tawil Contreras; Linda Curtis; Suzanne Carter, PhD, MS, MBA; Candace Fuller, PhD; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA

Scroll to Top